Inventor
FANNING LEV T D
US31 patents
⚠️ This page may combine multiple inventors who share the name “FANNING LEV T D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
17 patentsUS9051324B2Jun 9, 2015
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA56 citations98
US8999976B2Apr 7, 2015
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA105 citations98
US8969382B2Mar 3, 2015
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA66 citations98
US8785640B2Jul 22, 2014
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA72 citations98
US8748612B2Jun 10, 2014
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA64 citations98
US8604203B2Dec 10, 2013
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA73 citations98
US8367660B2Feb 5, 2013
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA85 citations98
US8633189B2Jan 21, 2014
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA68 citations97
US8614327B2Dec 24, 2013
Modulators of ATP-binding cassette transporters
VERTEX PHARMA78 citations97
US8343980B2Jan 1, 2013
Quinazoles useful as modulators of ion channels
VERTEX PHARMA8 citations82
US7799822B2Sep 21, 2010
Phenyl sulfonamides as modulators of ion channels
VERTEX PHARMA8 citations82
US7309716B2Dec 18, 2007
Benzimidazoles useful as modulators of ion channels
VERTEX PHARMA9 citations73
US7705031B2Apr 27, 2010
Benzimidazoles useful as modulators of ion channels
VERTEX PHARMA4 citations62
US7880008B2Feb 1, 2011
Heterocycles useful as modulators of ion channels
VERTEX PHARMA0 citations52
US8586589B2Nov 19, 2013
Piperidine and piperazine phenyl sulfonamides as modulators of ion channels
VERTEX PHARMA0 citations51
US12502376B2Dec 23, 2025
Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
VERTEX PHARMA0 citations48
US7705002B2Apr 27, 2010
Biaryls useful as modulators of ion channels
VERTEX PHARMA0 citations41
BINCH HAYLEY
6 patentsUS8552006B2Oct 8, 2013
Modulators of cystic fibrosis transmembrane conductance regulator
BINCH HAYLEY74 citations98
US8410132B2Apr 2, 2013
Modulators of cystic fibrosis transmembrane conductance regulator
BINCH HAYLEY89 citations98
US8314239B2Nov 20, 2012
Modulators of cystic fibrosis transmembrane conductance regulator
BINCH HAYLEY100 citations98
US8188283B2May 29, 2012
Modulators of cystic fibrosis transmembrane conductance regulator
BINCH HAYLEY97 citations98
US8598205B2Dec 3, 2013
Modulators of cystic fibrosis transmembrane conductance regulator
BINCH HAYLEY77 citations97
US8513282B2Aug 20, 2013
Modulators of cystic fibrosis transmembrane conductance regulator
BINCH HAYLEY84 citations97
WILSON DEAN
3 patentsUS8809353B2Aug 19, 2014
Quinazolines useful as modulators of voltage gated ion channels
WILSON DEAN0 citations51
US8329702B2Dec 11, 2012
Heterocycles useful as modulators of ion channels
WILSON DEAN0 citations51
US8158637B2Apr 17, 2012
Quinazolines useful as modulators of voltage gated ion channels
WILSON DEAN0 citations51